Atherosclerosis Drugs Market Scaling New Heights, with Hospital Pharmacies Contributing US$ 26 Bn by 2027, finds Fact.MR
Convenience and large inventory remain key points of attraction for consumers, which makes hospital pharmacies the primary distribution channel in the global atherosclerosis drugs market. However, growing dependence of individuals on retail pharmacies, on the back of easy accessibility, could negatively impact sales generation through hospital pharmacies. According to a recent study, retail pharmacies are projected to witness a CAGR of 2.9% during 2020-2027. Key Highlights of Atherosclerosis Drugs Market Study A shift from the development of branded drugs to generic…
You might be interested in
